Form 4 for NMTC NEUROONE MEDICAL TECHNOLOGIES Corp
Accepted 2022-02-04 00:00:00 ET · period of report 2022-02-03 · accession 0001709738-22-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-04 | 2022-02-03 | NMTC | Christianson Mark | Business Development Dir | A - Grant | $0.00 | +15.0K | 366.2K | +4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-03 | A | A | 15,000 | $0.00 | 366,169 | D | — | — | (F1) Represents a grant of restricted stock units, which vest as to 50% of the shares on the first anniversary of the grant date, with the remaining shares vesting in equal monthly installments on the last day of each month over the next 24 months, subject to continued service on such vesting date. |